| Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody D Corti, J Misasi, S Mulangu, DA Stanley, M Kanekiyo, S Wollen, ... Science 351 (6279), 1339-1342, 2016 | 404 | 2016 |
| Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus J Marcandalli, B Fiala, S Ols, M Perotti, W de van der Schueren, J Snijder, ... Cell 176 (6), 1420-1431. e17, 2019 | 379 | 2019 |
| Cross-neutralization of four paramyxoviruses by a human monoclonal antibody D Corti, S Bianchi, F Vanzetta, A Minola, L Perez, G Agatic, B Guarino, ... Nature 501 (7467), 439-443, 2013 | 274 | 2013 |
| An unbiased screen for human cytomegalovirus identifies neuropilin-2 as a central viral receptor N Martinez-Martin, J Marcandalli, CS Huang, CP Arthur, M Perotti, ... Cell 174 (5), 1158-1171. e19, 2018 | 236 | 2018 |
| Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer A Kabanova, J Marcandalli, T Zhou, S Bianchi, U Baxa, Y Tsybovsky, ... Nature microbiology 1 (8), 1-8, 2016 | 204 | 2016 |
| A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein J Tan, BK Sack, D Oyen, I Zenklusen, L Piccoli, S Barbieri, M Foglierini, ... Nature medicine 24 (4), 401-407, 2018 | 193 | 2018 |
| Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies A Kabanova, L Perez, D Lilleri, J Marcandalli, G Agatic, S Becattini, ... Proceedings of the National Academy of Sciences 111 (50), 17965-17970, 2014 | 140 | 2014 |
| The plant TPX2 protein regulates prospindle assembly before nuclear envelope breakdown JW Vos, L Pieuchot, JL Evrard, N Janski, M Bergdoll, D de Ronde, ... The Plant Cell 20 (10), 2783-2797, 2008 | 128 | 2008 |
| Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 JS Low, D Vaqueirinho, F Mele, M Foglierini, J Jerak, M Perotti, ... Science 372 (6548), 1336-1341, 2021 | 124 | 2021 |
| Differential Regulation of Cdc2 and Cdk2 by RINGO and Cyclins* 210 A Karaiskou, LH Perez, I Ferby, R Ozon, C Jessus, AR Nebreda Journal of Biological Chemistry 276 (38), 36028-36034, 2001 | 122 | 2001 |
| Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3) L Brambilla, D Genini, E Laurini, J Merulla, L Perez, M Fermeglia, ... Molecular oncology 9 (6), 1194-1206, 2015 | 95 | 2015 |
| Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells D Genini, L Brambilla, E Laurini, J Merulla, G Civenni, S Pandit, ... Proceedings of the National Academy of Sciences 114 (25), E4924-E4933, 2017 | 89 | 2017 |
| Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH/gL/pUL128L and trimer gH/gL/gO as well as antibodies elicited during primary HCMV … G Gerna, E Percivalle, L Perez, A Lanzavecchia, D Lilleri Journal of virology 90 (14), 6216-6223, 2016 | 87 | 2016 |
| Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial EA Bohula, BM Scirica, SE Inzucchi, DK McGuire, AC Keech, SR Smith, ... The Lancet 392 (10161), 2269-2279, 2018 | 85 | 2018 |
| Antibodies to combat viral infections: development strategies and progress G Pantaleo, B Correia, C Fenwick, VS Joo, L Perez Nature Reviews Drug Discovery 21 (9), 676-696, 2022 | 84 | 2022 |
| The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28 YD Muller, DP Nguyen, LMR Ferreira, P Ho, C Raffin, RVB Valencia, ... Frontiers in immunology 12, 639818, 2021 | 80 | 2021 |
| Characterization of a new family of cyclin-dependent kinase activators A Dinarina, LH Perez, A Davila, M Schwab, T Hunt, AR Nebreda Biochemical Journal 386 (2), 349-355, 2005 | 77 | 2005 |
| Antibody-guided vaccine design: identification of protective epitopes A Lanzavecchia, A Frühwirth, L Perez, D Corti Current opinion in immunology 41, 62-67, 2016 | 72 | 2016 |
| Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response V Glaros, R Rauschmeier, AV Artemov, A Reinhardt, S Ols, ... Immunity 54 (9), 2005-2023. e10, 2021 | 53 | 2021 |
| Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association S Palacios, LH Perez, S Welsch, S Schleich, K Chmielarska, F Melchior, ... Molecular biology of the cell 16 (6), 2822-2835, 2005 | 50 | 2005 |
Antonio LanzavecchiaNational Institute of Molecular Genetics, INGM, Milano, ITBestätigte E-Mail-Adresse bei ingm.org
